
BDH Industries Faces Significant Volatility Amidst Sector Underperformance and Trend Reversal
2025-03-06 09:35:13BDH Industries, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low today after two days of gains, experiencing significant intraday volatility. Over the past year, the company has faced challenges, with modest sales growth and a decline in stock performance compared to the broader market.
Read More
BDH Industries Hits 52-Week Low Amidst Ongoing Market Challenges and Volatility
2025-03-03 10:05:19BDH Industries, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low, reflecting a significant decline. The stock has underperformed its sector and recorded consecutive losses over the past week. Additionally, it is trading below key moving averages, indicating a bearish trend.
Read More
BDH Industries Faces Significant Volatility Amid Persistent Downward Trend in Pharmaceuticals Sector
2025-02-25 09:49:03BDH Industries, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low today amid significant volatility. The stock has underperformed its sector and is trading below multiple moving averages, reflecting a persistent downward trend over the past year, contrasting with the overall market performance.
Read More
BDH Industries Faces Bearish Trends Amid Broader Market Activity and Sector Underperformance
2025-02-24 12:35:11BDH Industries, a microcap in the Pharmaceuticals & Drugs sector, has seen significant trading activity as it nears its 52-week low. The stock has declined notably today, reversing a previous upward trend, and is currently trading below all major moving averages, reflecting ongoing challenges in the market.
Read More
BDH Industries Reports December 2024 Results: Operational Efficiency Up Amid Sales Decline
2025-02-15 10:17:17BDH Industries has released its financial results for the quarter ending December 2024, showcasing improved operating profit margins at 21.79%, the highest in five quarters. However, net sales declined to Rs 16.20 crore, marking a significant drop and the lowest figure in the same period, indicating sales challenges.
Read More
BDH Industries Faces Operational Challenges Despite Strong Management Efficiency in Q2 FY24-25
2025-02-10 18:35:56BDH Industries, a microcap in the Pharmaceuticals & Drugs sector, has recently experienced a grade adjustment amid flat financial performance for Q2 FY24-25. Despite challenges, the company demonstrates strong management efficiency with a notable return on equity and a low debt-to-equity ratio, indicating financial stability.
Read MoreClosure of Trading Window
26-Mar-2025 | Source : BSEThis is to inform that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time the trading window for dealing in the securities of the Company remains closed for designated persons from 1st April 2025 till 48 hours after the declaration of the Audited financial results for the quarter and year ended 31st March 2025 of the financial year 2024-2025.
Announcement under Regulation 30 (LODR)-Newspaper Publication
17-Feb-2025 | Source : BSEWe are enclosing herewith the Standalone Unaudited Financial Results for the third quarter and nine months ended on 31st December 2024 of the financial year 2024-25 published in newspapers.
Board Meeting Outcome for Outcome Of Board Meeting
14-Feb-2025 | Source : BSEThe Board of Directors of the Company approved the Standalone Unaudited Financial Results for the third quarter and nine months ended on 31st December 2024 of the financial year 2024-2025.
Corporate Actions
No Upcoming Board Meetings
BDH Industries Ltd has declared 45% dividend, ex-date: 02 Aug 24
No Splits history available
No Bonus history available
No Rights history available